1 Min Read
April 27 (Reuters) - Akari Therapeutics Plc
* Akari therapeutics plc says edison investment research ltd has withdrawn the report titled “akari’s coversin matches soliris in phase ii” Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.